Remove .Net Remove 2016 Remove Marketing Remove Sales
article thumbnail

Episona Gets $4M For Male Infertility Testing

socalTECH

According to Episona, the funding came from the Pasadena Angeles, as well as other high-net worth individuals from Pasadena and San Francisco. Episona has been offering up its test since October of 2016. Episona develops an epigenetic test which examines DNA for risk factors related to male factor fertility and poor embryo quality.

Pasadena 133
article thumbnail

Privacy Advocate Richard Holober on the Tech Backlash of 2017 

Xconomy

elections, democracy, free speech, fairness in hiring, sexual harassment, privacy, data security, and the future job market for humans in the age of robots and artificial intelligence. We’ve just passed a year full of news about the role of technology companies in U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. I widened my net this year. The results were so encouraging, we’re doing it again.

article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. —The FDA last summer approved two new cholesterol fighting drugs known as PCSK9 inhibitors, but so far the market has rejected them, resulting in paltry sales. Talk about sacrifice.

article thumbnail

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

Two days later, it paid AstraZeneca $550 million upfront for the rights to a group of antibiotics either already on the market or in late-stage testing. The deal also includes a $175 million deferred payment due in 2019 and $850 million in downstream payouts tied to regulatory and sales targets.

Pricing 40
article thumbnail

How To Embrace Disruptive Technologies And Succeed

Startup Professionals Musings

While struggling to net out what they are looking for, I found help in a new book, “ Wicked Strategies ,” by John C. These normally require an innovative new business model, non-linear thinking for marketing, sales, and distribution. In mature companies, no one wants to risk the existing market share or sunk costs.